Bruce Carlson[email protected]RheumaticDiagnostics wanted for emerging infections, tomorrow's pandemicsIn a 2018 global IVD market report, Kalorama Information lead analyst Shara Rosen wrote that the dark side of globalism is the spread of unwanted conditions. There are many examples of previously unknown or rare pathogens that spread and became a major problem globally -- this can happen rapidly with people traveling by air throughout the world, Rosen noted.June 18, 2020InfectiousBlood gas lab testing is one of a few winners, amid sagging volumes overallCritical care tests such as electrolytes and blood gases are essential for treatment decisions. Blood gas, or more specifically, arterial blood gas, is one of the most commonly used tests to measure oxygenation and blood acid levels and diagnose respiratory and renal conditions. If a COVID-19 patient cannot move oxygen into the blood and remove carbon dioxide from the blood, his or her respiratory system is critical.May 18, 2020Research and DevelopmentIndustry roundup: Oncology dominates noncoronavirus IVD newsThere's no doubt that COVID-19 tests remain a focal point for research and development -- IVD manufacturers have released scores of COVID-19 tests in the U.S. and Europe, as the decline in elective procedures dragged down demand for traditional diagnostics. But companies increasingly are announcing new non-COVID-19 innovations designed to help them stay competitive for when reopening occurs. We have also seen some merger activity, though reduced from the prepandemic days.April 30, 2020Diagnostic TechnologiesAI-based IVD rises to challenge of novel coronavirusAI in healthcare refers to the use of complex algorithms designed to perform certain tasks in an automated fashion. The algorithms can review, interpret, and even suggest solutions to complex medical problems.April 13, 2020COVID-19Cepheid set to start shipping 45-minute coronavirus POC testCepheid's Xpert Xpress SARS-CoV-2 test is the first POC product to receive an EUA, the FDA noted in a statement.March 22, 2020ImmunoassaysCould mPOC come to the rescue in COVID-19 outbreak?What IVD technology to use? Lab-based molecular IVD tests are in development, but they can't always be where the need is. Immunoassays take long periods to develop and, generally speaking, may not be sensitive enough for a "must-know" identification task of disease.March 5, 2020Research AllianceClinical laboratory market enjoys steady growth, exceeds $121BClinical laboratories are an essential part of the health industry, Kalorama noted. It is estimated that 70% to 80% of diagnoses by physicians result from laboratory tests, and clinical laboratory services are involved in 100% of patient care plans in oncology indications.Source: Kalorama Information.February 17, 2020Swine FluLaboratories, IVD vendors get to work on novel coronavirusThe first known cases emerged in December 2019 and were traced to an animal market in Wuhan, China, from patients who are believed to have come in contact with live animals that were infected. Wuhan is a large hub city with a population of 11Â million, located 500 miles from Shanghai. At the time of writing, 81 people had died from the virus and 2,700 were infected, with reports changing rapidly. The spread of the disease to other nations including the U.S. is a top story in the news media and, of course, a concern to laboratorians.January 27, 2020SequencingWhat's next for PacBio and Illumina?San Diego-based Illumina is the maker of the most successful sequencing products, including the MiSeq and NextSeq brands, with the largest share of the market, according to Kalorama Information's research. Pacific Biosciences develops long-read sequencers under the Sequel brand.January 15, 2020ConsumerTop 10 product news stories for 2019In fact, there were hundreds of developments in IVD testing in 2019 and selecting just 10 is a big challenge. But based on its decades of assessing and forecasting the market Kalorama Information selected the news items below as highly significant from the point of view of product advances.December 23, 2019Previous PagePage 5 of 7Next PageTop StoriesArtificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisThe automated analysis improved the rate of accurate genetic diagnosis, doubling the number of solved cases as compared with benchmarked methods, across three distinct real-world cohorts, according to researchers.StockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsEmerging TechnologyBiomarker extraction through ultrasound shows promise for cancer detectionSponsor ContentVisit our Molecular Diagnostics Community